Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

17.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.3K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.3K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

530
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
530
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

338
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease.

NPJ digital medicine·2026
Same author

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment.

The journal of prevention of Alzheimer's disease·2026
Same author

Gene deletion of Klotho in the dentate gyrus does not affect the number of adult-born granule cells.

Scientific reports·2026
Same author

Minor neuropsychological deficits and stage 2 of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Non-economic social deprivation and cognitive functioning later in life: Results from the DELCODE study.

Journal of Alzheimer's disease : JAD·2026
Same author

Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[From feeblemindedness to intellectual deficiency : Some comments from the forensic-psychiatric perspective on the replacement of the juridical term in the German Criminal Code (the criminal liability paragraph 20 StGB)].

Der Nervenarzt·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

[Innovation in diagnostics-mobile technologies].

Emrah Düzel1,2, Jochen René Thyrian3,4, David Berron5,6,7

  • 1Institut für Kognitive Neurologie und Demenzforschung (IKND), Magdeburg, Deutschland. Emrah.duezel@dzne.de.

Der Nervenarzt
|August 18, 2019
PubMed
Summary
This summary is machine-generated.

Mobile apps improve Alzheimer's disease cognitive assessment, overcoming limitations of traditional methods. This enhances patient care, enabling timely interventions and better use of advanced diagnostics for memory complaints.

Keywords:
Alzheimer’s diseaseCognitionMild cognitive impairmentMobile appsNeuropsychology

More Related Videos

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
07:25

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology

Published on: March 27, 2018

8.9K
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

8.0K

Related Experiment Videos

Last Updated: Jan 20, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K
Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
07:25

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology

Published on: March 27, 2018

8.9K
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

8.0K

Area of Science:

  • Neurology
  • Gerontology
  • Digital Health

Background:

  • Alzheimer's disease (AD) is characterized by progressive cognitive deficits, posing challenges for accurate assessment and monitoring.
  • Current diagnostic methods for cognitive impairment are often limited by their reliance on clinical settings and subjective measures.
  • Effective early intervention and patient care are hindered by the difficulties in precisely recording and tracking cognitive decline.

Purpose of the Study:

  • To identify challenges in current cognitive assessment practices for patients with memory problems.
  • To explore the potential of mobile applications in improving cognitive assessment and patient care for Alzheimer's disease.

Main Methods:

  • Review of existing care structures and relevant scientific literature.
  • Discussion of expert recommendations and emerging technological developments.
  • Evaluation of current diagnostic approaches and their limitations.

Main Results:

  • Traditional paper-and-pencil cognitive tests are constrained by time, location, and feasibility, impacting assessment validity and reliability.
  • These limitations hinder the effective use of advanced diagnostics like MRI and CSF analysis.
  • Mobile app technologies, exemplified by the neotiv app, offer a solution to overcome these assessment challenges.

Conclusions:

  • Mobile apps can significantly enhance cognitive assessment for individuals experiencing memory complaints, a key symptom of Alzheimer's disease.
  • These technologies can optimize diagnostic and therapeutic pathways, reducing both underuse and overuse.
  • Mobile applications facilitate targeted use of advanced diagnostics, support preventive measures, identify cognitive impairments, and empower patients.